Clinical Trial Update: A Phase I Clinical Study With Investigational Compound LTT462 in Adult Patients With Specific Advanced Cancers. [Phase 1]

View source ↗

Summary

Phase I trial update for investigational compound LTT462 in adults with advanced cancers; trial terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Non-small Cell Lung Carcinoma
• Other Solid Tumors
• Ovarian Neoplasms

Drugs mentioned

• LTT462

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Ovarian Neoplasms, Non-Small-Cell Lung Carcinoma | Phase 1 | Status: TERMINATED | Results posted: 2019-09-19